139 related articles for article (PubMed ID: 19880434)
1. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.
van Steenbergen LN; Rutten HJT; Creemers GJ; Pruijt JFM; Coebergh JWW; Lemmens VEPP
Ann Oncol; 2010 Jun; 21(6):1273-1278. PubMed ID: 19880434
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
[TBL] [Abstract][Full Text] [Related]
4. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
[TBL] [Abstract][Full Text] [Related]
5. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
6. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
7. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
[TBL] [Abstract][Full Text] [Related]
8. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
van Steenbergen LN; Lemmens VEPP; Rutten HJT; Wymenga ANM; Nortier JWR; Janssen-Heijnen MLG
Ann Oncol; 2012 Nov; 23(11):2805-2811. PubMed ID: 22562836
[TBL] [Abstract][Full Text] [Related]
9. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
10. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
[TBL] [Abstract][Full Text] [Related]
11. Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
van den Berg I; van de Weerd S; van Klaveren D; Coebergh van den Braak RRJ; van Krieken JHJM; Koopman M; Roodhart JML; Medema JP; IJzermans JNM
Eur J Surg Oncol; 2021 Aug; 47(8):2060-2068. PubMed ID: 33745794
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
[TBL] [Abstract][Full Text] [Related]
13. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
14. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Schrag D; Cramer LD; Bach PB; Begg CB
J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
[TBL] [Abstract][Full Text] [Related]
15. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
[TBL] [Abstract][Full Text] [Related]
16. Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older.
van Erning FN; Creemers GJ; De Hingh IH; Loosveld OJ; Goey SH; Lemmens VE
Ann Oncol; 2013 Nov; 24(11):2839-44. PubMed ID: 23933560
[TBL] [Abstract][Full Text] [Related]
17. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
[TBL] [Abstract][Full Text] [Related]
18. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
[TBL] [Abstract][Full Text] [Related]
19. Treatment and complications in elderly stage III colon cancer patients in the Netherlands.
Hoeben KW; van Steenbergen LN; van de Wouw AJ; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
Ann Oncol; 2013 Apr; 24(4):974-9. PubMed ID: 23136227
[TBL] [Abstract][Full Text] [Related]
20. Disparities in quality of care for colon cancer between hospitals in the Netherlands.
Elferink MA; Wouters MW; Krijnen P; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Siesling S; Tollenaar RA
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S64-73. PubMed ID: 20599339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
